Devyser Gets CLIA Certification for Atlanta Lab
The Sweden-based firm said it will use the laboratory to perform testing for hereditary diseases, oncology, post-transplant monitoring, and other patient management.
Top Five Articles on 360Dx Last Week: COVID Test Reimbursement Changes; Cue Health Layoffs; and More
Last week, readers were most interested in a story about how payor coverage of COVID-19 molecular and antigen tests will change this week.
CMS Announces Upcoming Changes to COVID-19 Test Reimbursement Policies
The changes, already anticipated by those in industry and government, will take effect on May 11, the scheduled end of the COVID-19 public health emergency.
Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test
Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.
Guardant Health Gets Medicare Coverage for Liquid Biopsy Treatment Response Test
The test is designed to track circulating tumor DNA levels in blood samples, enabling clinicians to evaluate patient responses to immunotherapy.